Weaver Consulting Group Raises Stock Holdings in Veru Inc. (NASDAQ:VERU)

Weaver Consulting Group increased its holdings in shares of Veru Inc. (NASDAQ:VERU) by 41.0% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 69,705 shares of the company’s stock after acquiring an additional 20,280 shares during the period. Weaver Consulting Group’s holdings in Veru were worth $45,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of VERU. Gladstone Institutional Advisory LLC increased its position in shares of Veru by 34.2% during the third quarter. Gladstone Institutional Advisory LLC now owns 56,876 shares of the company’s stock worth $44,000 after acquiring an additional 14,500 shares during the period. Blair William & Co. IL increased its holdings in Veru by 6.1% during the 2nd quarter. Blair William & Co. IL now owns 350,000 shares of the company’s stock worth $294,000 after purchasing an additional 20,000 shares during the period. Zacks Investment Management purchased a new position in Veru during the 3rd quarter worth $25,000. SG Americas Securities LLC raised its position in Veru by 185.9% during the 3rd quarter. SG Americas Securities LLC now owns 66,128 shares of the company’s stock valued at $51,000 after purchasing an additional 42,997 shares in the last quarter. Finally, Jane Street Group LLC lifted its holdings in shares of Veru by 142.8% in the 3rd quarter. Jane Street Group LLC now owns 96,454 shares of the company’s stock worth $74,000 after buying an additional 56,736 shares during the period. Hedge funds and other institutional investors own 47.16% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on VERU. Oppenheimer restated an “outperform” rating and issued a $5.00 price objective on shares of Veru in a report on Tuesday, November 5th. HC Wainwright restated a “buy” rating and issued a $3.00 price target on shares of Veru in a report on Thursday, January 2nd.

Veru Trading Down 1.2 %

VERU opened at $0.74 on Wednesday. The firm has a market cap of $108.95 million, a price-to-earnings ratio of -1.55 and a beta of -0.53. Veru Inc. has a 12 month low of $0.36 and a 12 month high of $1.92. The stock has a fifty day moving average price of $0.69 and a 200-day moving average price of $0.80.

Veru (NASDAQ:VERU) last announced its earnings results on Monday, December 16th. The company reported ($0.06) EPS for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.01. Veru had a negative net margin of 376.38% and a negative return on equity of 115.99%. On average, equities research analysts forecast that Veru Inc. will post -0.3 EPS for the current year.

About Veru

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.